查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1855844

2025年全球客製化基因检测市场报告

Customized Genetic Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，客製化基因检测市场发展迅速，预计将从2024年的121.6亿美元成长到2025年的141.3亿美元，复合年增长率达16.2%。过去一段时间的增长可归因于个性化医疗的日益普及、遗传性疾病病例的增加、基因检测在肿瘤学和药物基因组学领域的早期应用、测序技术的进步以及消费者对祖源和直接面向消费者的基因检测日益增长的兴趣。

预计未来几年，客製化基因检测市场将快速成长，到2029年市场规模将达255亿美元，复合年增长率（CAGR）为15.9%。推动这一成长的主要因素包括：全基因组定序成本的下降、其在预防性医疗保健领域的广泛应用、政府对基因组研究的支持、人工智慧在基因数据分析中的应用，以及诊断公司和製药公司在标靶治疗合作的加强。预计将出现的关键趋势包括：家用基因检测套组的普及、对多基因风险评分的日益重视、基于多体学的个人化医疗保健解决方案的构建、基因检测与基因咨询服务的结合以及利用区块链技术安全管理基因数据。

客製化基因检测是一种个人化的基因分析方法，它根据个人的独特需求（例如病历、家族健康背景、种族和具体临床问题）选择并检测特定的基因、变异或DNA区域。这种检测针对与患者病情最相关的基因，从而实现更准确的风险评估、诊断和管理。客製化基因检测可以帮助识别遗传疾病、指导治疗决策、预防疾病、进行生育规划，并支持精准医疗等领域的选择。

客製化基因检测的主要类型包括预测性检测、携带者检测、产前/新生儿检测、诊断性检测和药物基因组学检测。预测性检测旨在评估个体的遗传易感性，并在症状出现前预测其某些遗传疾病的风险。这种检测对于晚年发病的疾病尤其重要，有助于早期介入和知情决策。检测样本包括唾液、血液和口腔拭子，并采用次世代定序(NGS)、聚合酵素链锁反应(PCR)、微阵列分析和单细胞定序等技术进行分析。其应用领域涵盖肿瘤学、心血管疾病、神经系统疾病和代谢性疾病等，具体包括预测性检测、带因者检测、产前/新生儿检测、诊断性检测和药物基因组学检测。

美国在2025年春季突然提高关税及其引发的贸易摩擦正严重衝击医疗保健产业，尤其是关键医疗设备、诊断设备和药品的供应。医院和医疗机构面临进口手术器械、影像设备以及注射器、导管等耗材成本不断上涨的困境。这些成本的增加加剧了医疗预算的压力，导致一些医疗机构必须推迟设备升级或将成本转嫁给患者。此外，原料和零件的关税也阻碍了必需药品和医疗设备的生产，造成供应链瓶颈。为此，医疗产业正在寻求筹资策略多元化，尽可能促进在地化生产，并积极争取对紧急医疗产品实施关税豁免。

本研究报告是商业研究公司（The Business Research Company）全新系列报告的一部分，该系列报告提供客製化基因检测市场统计数据，包括全球客製化基因检测行业市场规模、区域份额、市场份额及竞争对手、详细的市场细分、市场趋势和商机，以及在定制基因检测行业取得成功所需的数据。这份客製化基因检测市场研究报告全面概​​述了您所需的一切信息，并对行业现状和未来发展趋势进行了深入分析。

未来几年，个人化医疗的日益普及预计将推动客製化基因检测市场的成长。个人化医疗是一种医疗保健方法，它根据每位患者的独特特征量身定制治疗方案、预防策略和医疗决策。基因组学、蛋白质组学和生物标记发现领域的进步推动了这一趋势，这些进步使得基于个别基因谱的治疗成为可能，从而带动了对标靶治疗、改进诊断和精准医疗解决方案的需求。客製化基因检测是这种方法的关键，它能够提供详细的基因讯息，用于准确评估疾病风险、制定个人化治疗方案和预防性医疗保健策略。例如，美国非营利组织个人化医疗联盟（Personalized Medicine Coalition）于2024年2月报告称，美国食品药物管理局）在2023年核准了16种用于治疗罕见疾病患者的新型个人化疗法。因此，个人化医疗的日益普及正在促进客製化基因检测市场的扩张。

客製化基因检测市场的主要企业正专注于面向消费者的直销产品，尤其是居家DNA检测与个人化医疗方案相结合的服务。居家DNA检测允许个人在诊所外采集唾液或口腔拭子样本。通常，使用者在线上或在药房订购套件，然后将其邮寄至实验室进行分析。例如，2025年5月，总部位于加拿大的数位健康技术公司Hydreight Technologies Inc.在其VSDHOne平台上推出了一项个人化基因检测和健康服务。该服务提供便利的居家DNA检测套组和客製化的健康方案，这些方案涵盖营养、健身、补充剂和药物相容性等方面。该平台还支援透过远端医疗服务和与合格医疗保健专业人员的面对面预约进行持续护理。

2025年3月，总部位于美国的精准医疗公司Tempos收购了Ambry Genetics，但未揭露金额。此次收购旨在透过将Ambry在遗传疾病诊断方面的经验与Tempos的人工智慧主导精准医疗平台结合，增强Tempos的市场地位并扩展其基因组检测能力。 Ambry Genetics同样总部位于美国，是一家知名的临床基因检测服务提供商，专注于支援遗传疾病诊断、癌症风险评估和精准医疗的次世代定序仪技术。

客製化基因检测市场包括提供个人化检测、诊断评估和客製化基因组报告等服务的营业单位所获得的收入。市场价值还包括服务供应商提供的或与服务供应商捆绑销售的相关商品的价值。此累计仅涵盖营业单位间交换或直接销售给最终消费者的商品和服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税，以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球客製化基因检测：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 终端用户产业分析
  • 全球客製化基因检测市场：成长率分析
  • 全球客製化基因检测市场表现：规模与成长，2019-2024年
  • 全球客製化基因检测市场预测：规模与成长，2024-2029年，2034年预测
  • 全球客製化基因检测：潜在市场规模 (TAM)

第六章 市场细分

  • 全球客製化基因检测市场依检测类型、效能和预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 预测性测试
  • 载体测试
  • 产前和新生儿检测
  • 诊断测试
  • 药物基因组学检测
  • 全球客製化基因检测市场依样本类型、效能和预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 唾液
  • 血
  • 口腔拭子
  • 全球客製化基因检测市场：依技术、效能和预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 下一代定序（NGS）
  • 聚合酵素链锁反应（PCR）
  • 微阵列分析
  • 单细胞定序
  • 全球客製化基因检测市场：依应用、效能和预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 肿瘤学
  • 心血管疾病
  • 神经系统疾病
  • 代谢紊乱
  • 全球客製化基因检测市场：依最终用户划分，实际值及预测值，2019-2024年、2024-2029年预测值、2034年预测值
  • 医院和诊所
  • 诊断实验室
  • 研究所
  • 全球客製化基因检测市场：按检测项目、类型、性能和预测进行细分，2019-2024年、2024-2029年预测、2034年预测
  • 癌症易感性检测
  • 神经退化性疾病检测
  • 心血管疾病风险检测
  • 代谢紊乱风险测试
  • 全球客製化基因检测市场：按带因者检测、类型、性能和预测进行细分，2019-2024年、2024-2029年预测、2034年预测
  • 囊肿纤维化带原者检测
  • 镰状细胞贫血带因者检测
  • 泰-萨克斯病带因者检测
  • 地中海贫血带因者检测
  • 全球客製化基因检测市场：按产前和新生儿检测、类型、性能和预测进行细分，2019-2024年、2024-2029年预测、2034年预测
  • 非侵入性产前检测（NIPT）
  • 新生儿筛检小组
  • 绒毛膜绒毛取样（CVS）
  • 基于羊膜穿刺术的基因检测
  • 全球客製化基因检测市场：依诊断测试、类型、效能和预测细分，2019-2024年、2024-2029年预测、2034年预测
  • 罕见疾病诊断
  • 肿瘤基因检测
  • 神经系统疾病诊断
  • 感染疾病相关基因检测
  • 全球客製化基因检测市场：依药物基因体学检测、类型、表现及预测细分，2019-2024年、2024-2029年预测、2034年预测
  • 药物代谢试验
  • 癌症药物基因体学
  • 心血管药物反应测试
  • 精神药物检测

第七章 区域和国家分析

  • 全球客製化基因检测市场：依地区、绩效及预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 全球客製化基因检测市场：按国家、绩效和预测划分，2019-2024 年、2024-2029 年预测、2034 年预测

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第十八章：法国市场

第十九章：义大利市场

第二十章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第三十章：竞争格局与公司概况

  • 客製化基因检测市场：竞争格局
  • 客製化基因检测市场：公司概况
    • Guardant Health Overview, Products and Services, Strategy and Financial Analysis
    • Tempus Overview, Products and Services, Strategy and Financial Analysis
    • Invitae Overview, Products and Services, Strategy and Financial Analysis
    • 23andMe Overview, Products and Services, Strategy and Financial Analysis
    • Labcorp Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Quest Diagnostics
  • Revvity Omics（PerkinElmer Genomics）
  • Natera
  • Myriad Genetics
  • BGI Genomics
  • CENTOGENE
  • Veracyte
  • Fulgent Genetics
  • LetsGetChecked
  • Helix
  • MedGenome
  • Baylor Genetics
  • Prenetics
  • Eurofins（Clinical Genetics）
  • Mapmygenome

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第35章：高潜力市场国家、细分市场与策略

  • 2029年客製化基因检测市场：提供新机会的国家
  • 2029年客製化基因检测市场：新兴细分市场机会
  • 2029年客製化基因检测市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章附录

简介目录
Product Code: r38493

Customized genetic testing is a personalized method of genetic analysis that selects specific genes, variants, or DNA regions to examine based on an individual's unique needs, such as medical history, family health background, ethnicity, or particular clinical concerns. This testing targets the genes most relevant to the patient's situation, enabling more accurate risk assessment, diagnosis, and management. Customized genetic testing helps identify inherited conditions, guide treatment decisions, and support choices in areas such as disease prevention, reproductive planning, and personalized medicine.

The primary test types of customized genetic testing are predictive testing, carrier testing, prenatal and newborn testing, diagnostic testing, and pharmacogenomic testing. Predictive testing involves examining an individual's genetic makeup to evaluate the risk of developing specific hereditary conditions before symptoms appear. It is especially valuable for conditions that manifest later in life, allowing for early interventions and informed decision-making. Samples used include saliva, blood, and buccal swabs, which are analyzed using next-generation sequencing (NGS), polymerase chain reaction (PCR), microarray analysis, and single-cell sequencing technologies. Applications cover areas such as oncology, cardiovascular diseases, neurological disorders, and metabolic disorders, and are applied across predictive testing, carrier testing, prenatal and newborn testing, diagnostic testing, and pharmacogenomic testing.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The customized genetic testing market research report is one of a series of new reports from The Business Research Company that provides customized genetic testing market statistics, including customized genetic testing industry global market size, regional shares, competitors with a customized genetic testing market share, detailed customized genetic testing market segments, market trends and opportunities, and any further data you may need to thrive in the customized genetic testing industry. This customized genetic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The customized genetic testing market size has grown rapidly in recent years. It will grow from $12.16 billion in 2024 to $14.13 billion in 2025 at a compound annual growth rate (CAGR) of 16.2%. The growth during the historical period is attributed to the increased adoption of personalized medicine, a rise in genetic disorder cases, early incorporation of genetic testing in oncology and pharmacogenomics, improvements in sequencing technologies, and a growing consumer interest in ancestry and direct-to-consumer genetic testing.

The customized genetic testing market size is expected to rapid growth in the next few years. It will grow to $25.50 billion in 2029 at a compound annual growth rate (CAGR) of 15.9%. The forecast growth period is driven by the decreasing cost of whole genome sequencing, broader uses in preventive healthcare, government support for genomics research, the integration of artificial intelligence in genetic data analysis, and heightened collaboration between diagnostic firms and pharmaceutical companies for targeted therapies. Key trends anticipated include a move toward at-home genetic testing kits, increased attention to polygenic risk scoring, the creation of multi-omics-based personalized healthcare solutions, greater emphasis on genetic counseling services alongside testing, and the use of blockchain technology for secure management of genetic data.

The rising adoption of personalized medicine is expected to drive the growth of the customized genetic testing market in the coming years. Personalized medicine is a healthcare approach where treatments, preventive strategies, and medical decisions are tailored to the unique characteristics of each patient. This trend is supported by advancements in genomics, proteomics, and biomarker discovery, enabling treatments based on individual genetic profiles and increasing demand for targeted therapies, improved diagnostics, and precision healthcare solutions. Customized genetic testing is essential in this approach, offering detailed genetic insights for accurate disease risk assessment, personalized treatments, and preventive care strategies. For example, in February 2024, the Personalized Medicine Coalition, a US nonprofit organization, reported that the United States Food and Drug Administration approved 16 new personalized treatments for rare disease patients in 2023, up from six approvals in 2022. As a result, the growing adoption of personalized medicine is contributing to the expansion of the customized genetic testing market.

Key companies in the customized genetic testing market are focusing on direct-to-consumer offerings, particularly at-home DNA testing combined with health plans tailored to individual genetic information. At-home DNA testing allows individuals to collect saliva or cheek swab samples outside clinical settings, typically by ordering a kit online or from a pharmacy and mailing it to a laboratory for analysis. For example, in May 2025, Hydreight Technologies Inc., a digital health technology company based in Canada, launched a personalized genetic testing and wellness service on its VSDHOne Platform. The service offers convenient access to at-home DNA testing kits and delivers customized health plans addressing nutrition, fitness, supplementation, and medication compatibility. The platform also supports ongoing care through telehealth services and in-person consultations with licensed healthcare professionals.

In March 2025, Tempus, a precision medicine company based in the United States, acquired Ambry Genetics for an undisclosed amount. This acquisition aims to enhance Tempus' position in the market and expand its genomic testing capabilities by combining Ambry's experience in inherited disease diagnostics with Tempus' artificial intelligence-driven precision medicine platform. Ambry Genetics, also based in the United States, is a prominent provider of clinical genetic testing, specializing in inherited disease diagnostics, cancer risk assessment, and next-generation sequencing technologies that support precision healthcare.

Major players in the customized genetic testing market are Guardant Health, Tempus, Invitae, 23andMe, Labcorp, Quest Diagnostics, Revvity Omics (PerkinElmer Genomics), Natera, Myriad Genetics, BGI Genomics, CENTOGENE, Veracyte, Fulgent Genetics, LetsGetChecked, Helix, MedGenome, Baylor Genetics, Prenetics, Eurofins (Clinical Genetics), Mapmygenome, Nebula Genomics.

North America was the largest region in the customized genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in customized genetic testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the customized genetic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The customized genetic testing market includes revenues earned by entities by providing services such as personalized testing, diagnostic evaluations, and customized genomic reporting. The market value also includes the worth of related goods supplied by service providers or bundled within their offerings. Only goods and services exchanged between entities or sold directly to end consumers are accounted for in this valuation.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Customized Genetic Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on customized genetic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for customized genetic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The customized genetic testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Test Type: Predictive Testing; Carrier Testing; Prenatal And Newborn Testing; Diagnostic Testing; Pharmacogenomic Testing
  • 2) By Sample Type: Saliva; Blood; Buccal Swab
  • 3) By Technology: Next-Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); Microarray Analysis; Single-Cell Sequencing
  • 4) By Application: Oncology; Cardiovascular Diseases; Neurological Disorders; Metabolic Disorders
  • 5) By End-User: Predictive Testing; Carrier Testing; Prenatal And Newborn Testing; Diagnostic Testing; Pharmacogenomic Testing
  • Subsegments:
  • 1) By Predictive Testing: Cancer Susceptibility Testing; Neurodegenerative Disorder Testing; Cardiovascular Disease Risk Testing; Metabolic Disorder Risk Testing
  • 2) By Carrier Testing: Cystic Fibrosis Carrier Testing; Sickle Cell Anemia Carrier Testing; Tay-Sachs Disease Carrier Testing; Thalassemia Carrier Testing
  • 3) By Type Prenatal And Newborn Testing: Non-Invasive Prenatal Testing (NIPT); Newborn Screening Panels; Chorionic Villus Sampling (CVS); Amniocentesis-Based Genetic Testing
  • 4) By Diagnostic Testing: Rare Disease Diagnosis; Oncology Genetic Testing; Neurological Disorder Diagnosis; Infectious Disease-Associated Genetic Testing
  • 5) By Pharmacogenomic Testing: Drug Metabolism Testing; Oncology Pharmacogenomics; Cardiovascular Drug Response Testing; Psychiatric Drug Response Testing
  • Companies Mentioned: Guardant Health; Tempus; Invitae; 23andMe; Labcorp; Quest Diagnostics; Revvity Omics (PerkinElmer Genomics); Natera; Myriad Genetics; BGI Genomics; CENTOGENE; Veracyte; Fulgent Genetics; LetsGetChecked; Helix; MedGenome; Baylor Genetics; Prenetics; Eurofins (Clinical Genetics); Mapmygenome; Nebula Genomics
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Customized Genetic Testing Market Characteristics

3. Customized Genetic Testing Market Trends And Strategies

4. Customized Genetic Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Customized Genetic Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Customized Genetic Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Customized Genetic Testing Market Growth Rate Analysis
  • 5.4. Global Customized Genetic Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Customized Genetic Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Customized Genetic Testing Total Addressable Market (TAM)

6. Customized Genetic Testing Market Segmentation

  • 6.1. Global Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Predictive Testing
  • Carrier Testing
  • Prenatal And Newborn Testing
  • Diagnostic Testing
  • Pharmacogenomic Testing
  • 6.2. Global Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Saliva
  • Blood
  • Buccal Swab
  • 6.3. Global Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Microarray Analysis
  • Single-Cell Sequencing
  • 6.4. Global Customized Genetic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oncology
  • Cardiovascular Diseases
  • Neurological Disorders
  • Metabolic Disorders
  • 6.5. Global Customized Genetic Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Diagnostic Laboratories
  • Research Institutes
  • 6.6. Global Customized Genetic Testing Market, Sub-Segmentation Of Predictive Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cancer Susceptibility Testing
  • Neurodegenerative Disorder Testing
  • Cardiovascular Disease Risk Testing
  • Metabolic Disorder Risk Testing
  • 6.7. Global Customized Genetic Testing Market, Sub-Segmentation Of Carrier Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cystic Fibrosis Carrier Testing
  • Sickle Cell Anemia Carrier Testing
  • Tay-Sachs Disease Carrier Testing
  • Thalassemia Carrier Testing
  • 6.8. Global Customized Genetic Testing Market, Sub-Segmentation Of Prenatal And Newborn Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Non-Invasive Prenatal Testing (NIPT)
  • Newborn Screening Panels
  • Chorionic Villus Sampling (CVS)
  • Amniocentesis-Based Genetic Testing
  • 6.9. Global Customized Genetic Testing Market, Sub-Segmentation Of Diagnostic Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Rare Disease Diagnosis
  • Oncology Genetic Testing
  • Neurological Disorder Diagnosis
  • Infectious Disease-Associated Genetic Testing
  • 6.10. Global Customized Genetic Testing Market, Sub-Segmentation Of Pharmacogenomic Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Metabolism Testing
  • Oncology Pharmacogenomics
  • Cardiovascular Drug Response Testing
  • Psychiatric Drug Response Testing

7. Customized Genetic Testing Market Regional And Country Analysis

  • 7.1. Global Customized Genetic Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Customized Genetic Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Customized Genetic Testing Market

  • 8.1. Asia-Pacific Customized Genetic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Customized Genetic Testing Market

  • 9.1. China Customized Genetic Testing Market Overview
  • 9.2. China Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Customized Genetic Testing Market

  • 10.1. India Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Customized Genetic Testing Market

  • 11.1. Japan Customized Genetic Testing Market Overview
  • 11.2. Japan Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Customized Genetic Testing Market

  • 12.1. Australia Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Customized Genetic Testing Market

  • 13.1. Indonesia Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Customized Genetic Testing Market

  • 14.1. South Korea Customized Genetic Testing Market Overview
  • 14.2. South Korea Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Customized Genetic Testing Market

  • 15.1. Western Europe Customized Genetic Testing Market Overview
  • 15.2. Western Europe Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Customized Genetic Testing Market

  • 16.1. UK Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Customized Genetic Testing Market

  • 17.1. Germany Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Customized Genetic Testing Market

  • 18.1. France Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Customized Genetic Testing Market

  • 19.1. Italy Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Customized Genetic Testing Market

  • 20.1. Spain Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Customized Genetic Testing Market

  • 21.1. Eastern Europe Customized Genetic Testing Market Overview
  • 21.2. Eastern Europe Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Customized Genetic Testing Market

  • 22.1. Russia Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Customized Genetic Testing Market

  • 23.1. North America Customized Genetic Testing Market Overview
  • 23.2. North America Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Customized Genetic Testing Market

  • 24.1. USA Customized Genetic Testing Market Overview
  • 24.2. USA Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Customized Genetic Testing Market

  • 25.1. Canada Customized Genetic Testing Market Overview
  • 25.2. Canada Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Customized Genetic Testing Market

  • 26.1. South America Customized Genetic Testing Market Overview
  • 26.2. South America Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Customized Genetic Testing Market

  • 27.1. Brazil Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Customized Genetic Testing Market

  • 28.1. Middle East Customized Genetic Testing Market Overview
  • 28.2. Middle East Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Customized Genetic Testing Market

  • 29.1. Africa Customized Genetic Testing Market Overview
  • 29.2. Africa Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Customized Genetic Testing Market Competitive Landscape And Company Profiles

  • 30.1. Customized Genetic Testing Market Competitive Landscape
  • 30.2. Customized Genetic Testing Market Company Profiles
    • 30.2.1. Guardant Health Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Tempus Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Invitae Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. 23andMe Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Labcorp Overview, Products and Services, Strategy and Financial Analysis

31. Customized Genetic Testing Market Other Major And Innovative Companies

  • 31.1. Quest Diagnostics
  • 31.2. Revvity Omics (PerkinElmer Genomics)
  • 31.3. Natera
  • 31.4. Myriad Genetics
  • 31.5. BGI Genomics
  • 31.6. CENTOGENE
  • 31.7. Veracyte
  • 31.8. Fulgent Genetics
  • 31.9. LetsGetChecked
  • 31.10. Helix
  • 31.11. MedGenome
  • 31.12. Baylor Genetics
  • 31.13. Prenetics
  • 31.14. Eurofins (Clinical Genetics)
  • 31.15. Mapmygenome

32. Global Customized Genetic Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Customized Genetic Testing Market

34. Recent Developments In The Customized Genetic Testing Market

35. Customized Genetic Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Customized Genetic Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Customized Genetic Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Customized Genetic Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer